A verification study of enhancement of the immune system
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000036610
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Not provided
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactation, or planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in anther clinical trial during trial period 9. Subjects who are ineligibility to participate in the study based on the evaluation of the principal physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scoring of immunological vigor * Assess the measured value at screening (before consumption) and at 4 weeks after consumption or calculate the amount of change.
- Secondary Outcome Measures
Name Time Method 1. T lymphocyte age 2. Number of T cells 3. CD4+T cells/CD8+ T cells ratio 4. Number of naive T cells 5. Naive T cells/memory T cells ratio 6. Number of B cells 7. Number of NK cells 8. Number of CD8+CD28+T cells 9. Subjective symptoms (The Likert scale method) *1-8 Assess the measured value at screening (before consumption) and at 4 weeks after consumption or calculate the amount of change. *9 Assess the measured value at screening (before consumption) and at 4 weeks after consumption.